Zobrazeno 1 - 10
of 11
pro vyhledávání: '"John Disouza"'
Publikováno v:
Future Journal of Pharmaceutical Sciences, Vol 10, Iss 1, Pp 1-16 (2024)
Abstract Background Docetaxel (DTX) finds extensive use in treating various cancers, but its limited solubility, side effects, and multi-drug resistance (MDR) hinder its effectiveness. To enhance DTX's properties, the study aimed to formulate DTX-loa
Externí odkaz:
https://doaj.org/article/c36dcbe4489f4d82abaa603920dbe9ad
Publikováno v:
Journal of Research in Pharmacy. 27:825-836
Publikováno v:
Asian Journal of Pharmacy and Technology. :299-304
Tenoxicam (TNX) is an effective non-steroidal anti-inflammatory drug (NSAIDs) used to treat rheumatoid arthritis. Like other NSAIDs, tenoxicam has the disadvantage of being linked to gastrointestinal side effects. Furthermore, this drug is having wea
Autor:
Jaskiran, Kaur, Monica, Gulati, Niraj Kumar, Jha, John, Disouza, Vandana, Patravale, Kamal, Dua, Sachin Kumar, Singh
Publikováno v:
Drug Discovery Today. 27:1495-1512
Polymeric micelles (PMs) have been explored pre-clinically for the delivery of chemotherapeutics to treat cancer. Their unique features, such as easy surface functionalization, stimuli-responsiveness, good stability, ability to modify drug release, e
Autor:
Popat Kumbhar, Kaustubh Kolekar, Chinmayee Khot, Swati Dabhole, Ahmad Salawi, Fahad Y. Sabei, Akshay Mohite, Kapil Kole, Susmit Mhatre, Niraj Kumar Jha, Arehalli Manjappa, Sachin Kumar Singh, Kamal Dua, John Disouza, Vandana Patravale
Publikováno v:
Journal of controlled release : official journal of the Controlled Release Society. 353
Cancer ranks as the second foremost cause of death in various corners of the globe. The clinical uses of assorted anticancer therapeutics have been limited owing to the poor physicochemical attributes, pharmacokinetic performance, and lethal toxiciti
Autor:
Popat KUMBHAR, Vıshvajıt KHADE, Varsha KHADAKE, Pradnya MARALE, Arehallı MANJAPPA, Sameer NADAF, Vıjay KUMBAR, Durgacharan BHAGWAT, John DİSOUZA
Publikováno v:
Fabad Journal of Pharmaceutical Sciences.
Background: Ifosfamide (IFS) is proved efficacious against breast cancer, an enormously diagnosed cancer across the globe. However, the clinical efficacy of IFS is limited owing to its hydrophilicity, less stability, and dose-dependent toxicities. Th
Autor:
Leander Corrie, Monica Gulati, Ankit Awasthi, Sukriti Vishwas, Jaskiran Kaur, Rubiya Khursheed, Omji Porwal, Aftab Alam, Shaik Rahana Parveen, Hardeep Singh, Dinesh Kumar Chellappan, Gaurav Gupta, Popat Kumbhar, John Disouza, Vandana Patravale, Jon Adams, Kamal Dua, Sachin Kumar Singh
Publikováno v:
Chemico-biological interactions. 368
Polysaccharides (PS) represent a broad class of polymer-based compounds that have been extensively researched as therapeutics and excipients for drug delivery. As pharmaceutical carriers, PS have mostly found their use as adsorbents, suspending agent
Autor:
Shaik Rahana Parveen, Sheetu Wadhwa, Molakpogu Ravindra Babu, Sukriti Vishwas, Leander Corrie, Ankit Awasthi, Farhan R. Khan, Maha M. Al-Bazi, Nahed S. Alharthi, Faisal Alotaibi, Gaurav Gupta, Narendra Kumar Pandey, Bimlesh Kumar, Popat Kumbhar, John Disouza, Monica Gulati, Jayanthi Neelamraju, Ratna Sudha Madempudi, Kamal Dua, Sachin Kumar Singh
Publikováno v:
Journal of Drug Delivery Science and Technology. 84:104411
Publikováno v:
Microchemical Journal. 185:108310
Autor:
Popat Kumbhar, Kapil Kole, Tejashree Yadav, Ashwini Bhavar, Pramod Waghmare, Rajdeep Bhokare, Arehalli Manjappa, Niraj Kumar Jha, Dinesh Kumar Chellappan, Sunita Shinde, Sachin Kumar Singh, Kamal Dua, Ahmad Salawi, John Disouza, Vandana Patravale
Publikováno v:
European journal of pharmacology. 926
Skin cancer is one of the most common forms of cancer. Several million people are estimated to have affected with this condition worldwide. Skin cancer generally includes melanoma and non-melanoma with the former being the most dangerous. Chemotherap